Latest Articles

Publication Date
All News Scientific
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz

Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz

Published: May 19, 2026, 6:54 a.m.
Read Full Article
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer - Targeted Oncology

Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer Targeted Oncology

Published: May 18, 2026, 1:33 p.m.
Read Full Article
Merck endometrial cancer drug meets survival goals in phase 3 trial - StreetInsider

Merck endometrial cancer drug meets survival goals in phase 3 trial StreetInsider

Published: May 18, 2026, 10:47 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Endometriosis, particularly ovarian endometrioma, is associated with a 2-fold increased risk of ovarian cancer (OC), especially the clear cell and endometrioid subtypes. However, the absolute lifetime risk of OC in …

Published: May 17, 2026, midnight
Read Full Article
biomarkers contraception endometriosis hormonal treatment oral contraceptives ovarian cancer surgery survival ultrasound
Common Gynecologic Issues in Patients Post-Kidney Transplantation.

Advances in kidney transplantation have transformed survival and quality of life for women with end-stage renal disease, necessitating a focus on long-term health care for this population. Female kidney transplant …

Published: May 15, 2026, midnight
Read Full Article
gynecology kidney transplant reproductive health women's health
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)

Published: May 12, 2026, 7:56 p.m.
Read Full Article
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care

Published: May 12, 2026, 7:56 p.m.
Read Full Article
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)

Published: May 12, 2026, 7:52 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!